Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Johnson and Johnson
Boehringer Ingelheim
Dow
Colorcon

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018240

See Plans and Pricing

« Back to Dashboard

NDA 018240 describes TENORMIN, which is a drug marketed by Astrazeneca and Alvogen and is included in two NDAs. It is available from one supplier. Additional details are available on the TENORMIN profile page.

The generic ingredient in TENORMIN is atenolol. There are thirty-four drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the atenolol profile page.
Summary for 018240
Tradename:TENORMIN
Applicant:Alvogen
Ingredient:atenolol
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018240
Mechanism of ActionAdrenergic beta-Antagonists
Suppliers and Packaging for NDA: 018240
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TENORMIN atenolol TABLET;ORAL 018240 NDA Almatica Pharma Inc. 52427-429 52427-429-90 90 TABLET in 1 BOTTLE (52427-429-90)
TENORMIN atenolol TABLET;ORAL 018240 NDA Almatica Pharma Inc. 52427-430 52427-430-90 90 TABLET in 1 BOTTLE (52427-430-90)
Paragraph IV (Patent) Challenges for 018240
Tradename Dosage Ingredient NDA Submissiondate
TENORMIN TABLET;ORAL atenolol 018240

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 004

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Apr 9, 1990TE:ABRLD:Yes

Expired US Patents for NDA 018240

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen TENORMIN atenolol TABLET;ORAL 018240-004 Apr 9, 1990   Start Trial   Start Trial
Alvogen TENORMIN atenolol TABLET;ORAL 018240-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Alvogen TENORMIN atenolol TABLET;ORAL 018240-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
McKesson
Express Scripts
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.